本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lyra Therapeutics

7.90
-0.6500-7.60%
盤後7.900.00000.00%19:42 EDT
成交量:5.97萬
成交額:48.26萬
市值:1,262.70萬
市盈率:-0.13
高:8.52
開:8.48
低:7.85
收:8.55
資料載入中...
2024/02/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/07/06

SEC問詢函

Form CORRESP - Correspondence
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]